Umi No Shizuku Fucoidan's commitment

We make our best efforts in the selection of raw ingredients, quality control, proprietary blending as well as active ingredient research to offer a product that not only helps protect health but also boosts our customers’ confidence.

Our Commitments:
Our Fucoidan is different in 6 different ways.
Commitment 1 Commitment 1
Fucoidan MIX AG
(Fucoidan + Agaricus)

Umi No Shizuku Fucoidan is the unique formula known as “Fucoidan Mix AG”. It’s a perfect blend of fucoidan and Agaricus, ingredients harvested from the sea and land, respectively. Agaricus is a fungus in the family of Agaricaceae, called “the mushroom of God” in Brazil. It is rich in health-supporting glucose in the form of polysaccharide β-glucan.

Ingestion of Fucoidan Mix AG (two types of fucoidan and Agaricus mycelium blended in a fixed ratio) yields a greater effect on protecting health without placing a burden on the body than taking fucoidan and Agaricus mycelium separately. Fucoidan Mix AG is the reason why people choose Umi No Shizuku Fucoidan from among many existing fucoidan products.

Fucoidan MIX AG(Fucoidan + Agaricus)
Commitment 2 Commitment 2
High quality ingredients of Umi No Shizuku Fucoidan

From raw ingredients to manufacturing, Umi No Shizuku Fucoidan is produced, within Japan, under strict quality control. We make efforts to maintain quality and safety every day.

  • Fucoidan is a rare ingredient, extracted in a ratio of 1 per 100 parts of unprocessed mozuku. Umi No Shizuku Fucoidan contains an extremely high level of fucoidan, extracted from mozuku that can be only be harvested in Okinawa.
  • The number of sulfate groups said to be the “life force” of fucoidan, decrease when fucoidan is extracted from dried mozuku in the manufacturing process. As Umi No Shizuku Fucoidan uses Okinawa mozuku and is processed immediately when harvested, it excels in both its fucoidan and sulfate group content.
Harvesting Okinawa Mozuku
Commitment 3 Commitment 3
Medical Research with NPO Fucoidan Research Institue

As a member company of the NPO Research Institute of Fucoidan, Umi No Shizuku Fucoidan has worked toward research into fucoidan. The institute’s research into fucoidan analyzes its functions. Day by day, we continue working with researchers to enhance the quality and effectiveness of Umi No Shizuku Fucoidan.

We have presented the findings of this joint research with national universities at academic meetings related to immunity and health foods. In particular, we have presented many research findings at the IMMUNOLOGY Annual Meeting of The American Association of Immunologists.

Medical Doctor Daisuke Tachikawa Daisuke Tachikawa M.D. Director NPO Research Institute of Fucoidan / Assistant Director, Shusuido Wakamiya Hospital


M.D. Daisuke Tachikawa

After graduating from the School of Medicine at Fukuoka University, Dr. Tachikawa undertook clinical work as a surgeon in the Department of Orthopaedics/Plastic Surgery of the university hospital. He then studied at the Graduate School of Medical Sciences at Fukuoka University, where he engaged in research on cancer and chemotherapy for many years. In 2000, he was chosen to receive the Fukuoka University Medical Association Award. In 2004, he featured in the Who’s Who in Medicine and Healthcare (Marquis Who’s Who LLC, 5th Edition USA). In 2005, he qualified as a food quality advisor. His published works include The Amazing Power of Fucoidan: The Key to Conquering Cancer (edited by Seaweed Fucoidan Reporting Group, supervised by Dr. Daisuke Tachikawa).


Ph.D. Yoshiyuki Miyazaki Yoshiyuki Miyazaki Ph.D.; Associate Professor Kyushu University; Director Research Institute of Fucoidan


Ph.D. Yoshiyuki Miyazaki

Dr. Miyazaki involved in the research of food functionality at the Graduate School of Agriculture, Kyushu University, obtaining his doctorate in 2003. Subsequently, he engaged in basic research in immunology, as a first postdoctoral researcher at the School of Medicine, Kyushu University and as a research associate at Saga Medical School Faculty of Medicine, Saga University.

In January 2010, he joined NPO Research Institute of Fucoidan as a Principal Investigator. He served as the President of the Institute from August 2010 through September 2014. Since October 2014, he has worked as an Academic Researcher at the Graduate School of Agriculture, Kyushu University, and in April 2016 was appointed Associate Professor of the Laboratory of Bioactive Polysaccharide Analysis.

Medical Research with NPO Fucoidan Research Institute

As a member company of the NPO Research Institute of Fucoidan, Umi No Shizuku Fucoidan has worked toward research into fucoidan. The institute’s research into fucoidan analyzes its functions. Day by day, we continue working with researchers to enhance the quality and effectiveness of Umi No Shizuku Fucoidan.

We have presented the findings of this joint research with national universities at academic meetings related to immunity and health foods. In particular, we have presented many research findings at the IMMUNOLOGY Annual Meeting of The American Association of Immunologists.


The American Association of Immunologists. IMMUNOLOGY 2016, May 13-17, 2016. AAI Annual Meeting, Seattle, Washington. IMMUNOLOGY 2018, May 4-8, 2018. AAI Annual Meeting, Austin, Texas.

Medical Doctor Daisuke Tachikawa Daisuke Tachikawa M.D. Director NPO Research Institute of Fucoidan / Assistant Director, Shusuido Wakamiya Hospital

Ph.D. Yoshiyuki Miyazaki Yoshiyuki Miyazaki Ph.D.; Associate Professor Kyushu University; Director Research Institute of Fucoidan

Commitment 4 Commitment 4
Umi No Shizuku Fucoidan has obtained safety certificate and award

Pursuing safety from the beginning, we have been certified under several standards and criteria for our long history of procuring high-quality ingredients and thorough quality control.

  • In February 2018, Umi No Shizuku Fucoidan was named a Certified Health Food (JHFA) by the Japan Health and Nutrition Food Association. A certification mark awarded only to those fucoidan products that clear strict criteria.
  • In 2006, our product became the first fucoidan-related health supplement food to receive the Monde Selection Gold Award, which we subsequently received again in 2012 and 2016.
  • Our products also undergo regular radiation testing by SGS, the world’s largest inspection and authentication body, and pass testing every time.
  • Similarly, the products regularly undergo radiation inspection by Japan Food Research Laboratories (JFRL), passing every time.
  • We perform manufacturing at a plant certified under cGMP food quality standards. Also, meeting requirements of FDA in USA.
  • Certified by PCCW Hong Kong - The Excellence Brand Award (The Outstanding Retail Fucoidan Award)
  • Awarded by the Hong Kong Health Care Federation - Health Care Professional's Most Prominent Health Brand
Umi No Shizuku Fucoidan has obtained safety Certificate and award
Commitment 5 Commitment 5
Sales record in 45 countries worldwide.

Since 2002, Umi No Shizuku Fucoidan has been sold in 45 countries including Japan. We now have branches in the US, Canada, Hong Kong, South Korea, Vietnam, Singapor, Taiwan, and Thailand, with all of our sites cooperating to act as one.

Sales record in 45 countries worldwide.
Commitment 6 Commitment 6
3 types of Umi No Shizuku Fucoidan Supplement

Health conditions and lifestyle patterns differ for every individual. Umi No Shizuku Fucoidan has developed three types of products to serve a wide range of customer groups. Therefore, select the product that fits your intended use.

  • Powder type
    Fucoidan Mix AG (Proprietary ingredient in Umi No Shizuku Fucoidan, blending mozuku fucoidan, mekabu fucoidan, and Agaricus mycelium) in a proprietary ratio, made easily ingestible with young barley leaves, green tea, and brewer’s yeast. This product is made for easy drinkings, like tea.
    (High molecular weight fucoidan content: 100mg/packet)
  • Capsule type
    Pure Fucoidan Mix AG, in an easily ingested, vegetable-based capsule. The capsule can be taken with water or warm water Umi No Shizuku Fucoidan is a natural health product made from the Mozuku and Mekabu seaweeds and Agaricus mycelium extracts. The capsule size of the Umi No Shizuku Fucoidan is smaller than the normal capsule, which is easily taken by patients. The capsule casing is made from plant-based fibers and can be taken by vegetarians. The capsules are easily digested and will not be a burden on the stomach.
    (High molecular weight fucoidan content: 212.5mg/capsule)
  • Drink type
    Each bottle drink type contains about 10 capsules equivalent of fucoidan content, which is more concentrated and targeted for patients with swallowing difficulty or with oral, esophageal, and gastric abnormal cells. When taking the drink type, let the liquid stay for 10-30 seconds in the mouth and then swallow, so the high molecular weight fucoidan may act directly on the abnormal cells in the mouth, esophagus, and stomach, which can be absorbed to act directly. Because the drink does not contain preservatives, once opened please store the unfinished drinks in the refrigerator, and consume within the day. Store the unopened drinks at room temperature and a cool, dry place.
    (High molecular weight fucoidan content: 2,125mg/bottle)
3 types of Uminoshizuku Supplement
Fucoidan Umi No Shizuku customer center